ReviewLeukemia & lymphoma2011

Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease state.

Tomasz SkorskiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.